Top Abstract Purchase Related
Home
>
Node
>
Subnode

Biological response modifiers. Interferons, interleukins, and transfer factor

Kirkpatrick, C.H.

Annals of Allergy 62(3): 170-176

1989

ISSN/ISBN: 0003-4738
PMID: 2466425
Document Number: 328208
Natural consequences of knowledge of the mechanisms that regulate immune responses are the attempts to modify the immune system in order to increase resistance to infectious diseases and to enhance activity against tumor cells. This review describes the roles of interferons and interleukins in immune responses and reviews the experience with transfer factor in treatment of certain diseases.

Document emailed within 1 workday
Secure & encrypted payments

Sodhi, A.; Pai, K. 1992: Studies on the release of interleukin-1 (IL-1), tumor necrosis factor (TNF) and lysozyme from human non-adherent mononuclear cells (nMNC) in vitro after treatment with cisplatin and other biological response modifiers Neoplasma 39(4): 211-217
Ackermann, R. 1988: Biological response modifiers in renal cancer Progress in Clinical and Biological Research 269: 313-328
Ishihara, K. 1989: On the behalf of the Japanese Society of Biological Response Modifiers Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Pt 2-1): 906-911
Scheinberg, M.A. 1988: Clinical trials with biological response modifiers in rheumatic diseases Journal of Rheumatology 15(7): 1056-1057
Zlotta, A.R.; Schulman, C.C. 2000: Biological response modifiers for the treatment of superficial bladder tumors European Urology 37(Suppl): 10-15
Okawa, T.; Goto, M.; Kita, M. 1987: Radiotherapy combined with BRM (biological response modifiers) in the treatment of cancer Gan no Rinsho. Japan Journal of Cancer Clinics 33(10): 1253-1256
Saito, A. 2001: A putative immunotherapy with biological response modifiers (BRM) against intractable pulmonary tuberculosis Kekkaku: 76(12): 741-747
Muss, H.B. 1988: The role of biological response modifiers in metastatic renal cell carcinoma Seminars in Oncology 15(5 Suppl 5: 30-34
Irwin, M.M. 1987: Patients receiving biological response modifiers: overview of nursing care Oncology Nursing Forum 14(6 Suppl): 32-37
Koga, H.; Miyazaki, Y.; Kohno, S.; Hara, K. 1994: A drug delivery system and biological response modifiers for the treatment of mycobacterial infection Kekkaku: 69(2): 113-118
Talmadge, J.E.; Herberman, R.B. 1986: The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers Cancer Treatment Reports 70(1): 171-182
Bergmann, L. 1989: Malignant melanoma--prognosis and actual treatment strategies with chemotherapy and biological response modifiers European Journal of Cancer and Clinical Oncology 25(Suppl 3): S31-S36
Lobodzińska, M.; Biernacka, I.; Skurska, Z. 1973: Rat interferons. I. Biological properties of interferons in rat serum Archivum Immunologiae et Therapiae Experimentalis 21(3): 461-469
Nio, Y.; Zighelboim, J.; Berek, J.S.; Bonavida, B. 1990: Augmentation of cytotoxicity of lymphokine activated killer cells on ovarian tumor cells by various biological response modifiers Anticancer Research 10(2a): 441-446
Buc, M.; Siska, P.; Rovenský, J.; Pruzinec, P.; Stefanovic, J.; Pekárek, J.; Svejcar, J. 1982: Changes in T-lymphocyte response under the action of transfer factor in vivo Bratislavske Lekarske Listy 78(1): 63-73
Chybicka, A. 1994: Interleukins--biological functions and clinical use Acta Haematologica Polonica 25(2 Suppl 1: 21-31
Smith, C.R.; Griffin, D.E.; Graybill, J.R. 1976: Chronic pulmonary histoplasmosis: improved lymphocyte response with transfer factor Annals of Internal Medicine 84(6): 708-709
Pawłowska, M.łg. 2005: HCV: immune response and its modifiers in clinical development Przeglad Epidemiologiczny 59(2): 519-523
Markenson, J. 2007: Safety and efficacy of the biologic response modifiers American Journal of Orthopedics 36(3 Suppl): 15-19
Burke, D.C. 1977: Biological properties of virus-induced interferons Texas Reports on Biology and Medicine 35: 11-16